Update information

Update information

October 2019: A footnote has been added to recommendations in section 1.3 on PPI and H2RA licensing for use in children. Recommendation 1.3.7 has been amended to clarify when metoclopramide, domperidone or erythromycin can be offered.

ISBN: 978-1-4731-0931-5

  • National Institute for Health and Care Excellence (NICE)